Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
13.22
+0.09 (0.69%)
At close: Sep 26, 2025, 4:00 PM EDT
13.21
-0.01 (-0.08%)
After-hours: Sep 26, 2025, 7:04 PM EDT
Adaptive Biotechnologies Employees
Adaptive Biotechnologies had 619 employees as of December 31, 2024. The number of employees decreased by 90 or -12.69% compared to the previous year.
Employees
619
Change (1Y)
-90
Growth (1Y)
-12.69%
Revenue / Employee
$331,528
Profits / Employee
-$195,847
Market Cap
2.01B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ADPT News
- 17 days ago - Adaptive Biotechnologies Corporation (ADPT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Aristotle Focus Growth Q2 Highlights: Top Performers, Surprises And Strategic Shifts - Seeking Alpha
- 7 weeks ago - Adaptive Biotechnologies Corporation (ADPT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Adaptive Biotechnologies Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025 - GlobeNewsWire
- 3 months ago - Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ® MRD Testing into OncoEMR® - GlobeNewsWire
- 4 months ago - Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers - GlobeNewsWire